缺血性中风后的出血转变,在以高纤维素溶解为基础的基本血栓细胞血症的情况下,在血栓等离子学上进行
Daisuke Kudo1, Kotaro Noda1, Motohiro Suzuki1
1Department of Neurology and Neurological Science, Institute of Science Tokyo Hospital, Japan.
Internal medicine (Tokyo, Japan)
|December 17, 2025
概括
基本血小板血 (ET) 管理需要平衡凝血. 血栓形成显微镜 (TEG) 监测,特别是30分钟后的溶解指数 (LY30),可能有助于管理经历血栓栓塞事件的ET患者.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床凝血 临床凝血
背景情况:
- 基本血小板血 (ET) 是一种由血小板数升高标志的骨髓增殖性瘤.
- ET患者面临血栓栓塞和出血并发症的风险.
- 维持凝血平衡对于管理ET患者至关重要.
研究的目的:
- 为了研究血栓显微镜 (TEG) 在监测ET患有缺血性中风的患者的凝血状况时的实用性.
- 评估TEG参数与ET中的出血转化之间的相关性.
主要方法:
- 一个ET患者经历缺血性中风的案例报告.
- 采用血栓凝聚力学 (TEG) 来评估全血凝固动态.
- 在出血转化期间30分钟后监测的溶解指数 (LY30).
主要成果:
- 患者呈现出缺血性中风和ET.
- 在出血转化期间观察到30分钟后溶解指数升高 (LY30).
- 细胞减少疗法导致血小板计数和LY30水平的正常化.
结论:
- 血栓形成显微镜 (TEG) 可能成为监测ET患者复杂凝血状况的宝贵工具.
- 像LY30这样的TEG参数可能表明ET的出血风险正在演变.
- 这一案例凸显了TEG在指导ET患者管理方面的潜力.
相关概念视频
Extrinsic and Intrinsic Pathways of Hemostasis
11.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis I: Introduction
294
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
294
Clot Retraction and Fibrinolysis
8.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.3K
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Introduction to Hemostasis
13.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.0K


